Maze Therapeutics Inc
MAZEHealthcare|Biotechnology|USA
$30.56
-1.89 (-5.82%)
Tangible Book
$6.87
Clinical Trials (3)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06830629 A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease | Proteinuric Kidney Disease | P2 | Recruiting | 56 | Open-label | MZE829 |
| NCT07694440 A Phase 2 Study of MZE782 in Adults With PKU | Phenylketonuria (PKU) | P2 | Recruiting | 38 | RCT, Double-blind | MZE782, MZE782 |
| NCT05249621 A Randomized Phase 1 of of MZE001 in Healthy Volunteers | Healthy | P1 | Completed | 121 | RCT, Double-blind | MZE001, Placebo |